Abstract
Purpose
To evaluate ocular findings of patients with acute cerebral infarction by analyzing fluorescein angiography (FAG) and optical coherence tomography (OCT).
Methods
We retrospectively reviewed the medical records of patients with acute cerebral infarction. FAG was used to analyze arm to retina time and arteriovenous (AV) transit time. The peripapillary retinal nerve fiber layer (pRNFL) was analyzed using OCT, and the data were compared with those of patients diagnosed with idiopathic epiretinal membrane (control group).
Results
Seventy-three patients were included in the patient group, and 56 participants were in the control group. In 27% of the subjects in the patient group, retinal abnormality was incidentally identified. Atrial fibrillation (p < 0.050) was the only systemic disease with a significantly higher incidence in the patient group. AV transit time (p < 0.050) showed a significant delay in the patient group, but there was no significant difference in the arm to retina time. pRNFL thickness did not significantly differ between the ipsilateral and contralateral locations of brain lesion. In addition, there was no significant difference in the subgroup analysis according to cerebral ischemic territory and no correlation between the severity of symptoms and the findings of ophthalmologic examination.
References
2. Douglas DJ, Schuler JJ, Buchbinder D. . The association of central retinal artery occlusion and extracranial carotid artery disease. Ann Surg. 1988; 208:85–90.
![crossref](/image/icon/bnr_ref_cross.gif)
![crossref](/image/icon/bnr_ref_cross.gif)
3. Park SJ, Choi NK, Seo KH. . Nationwide incidence of clin-ically diagnosed central retinal artery occlusion in Korea, 2008 to 2011. Ophthalmology. 2014; 121:1933–8.
![crossref](/image/icon/bnr_ref_cross.gif)
![crossref](/image/icon/bnr_ref_cross.gif)
4. Benavente O, Eliasziw M, Streifler JY. . Prognosis after tran-sient monocular blindness associated with carotid-artery stenosis. N Engl J Med. 2001; 345:1084–90.
![crossref](/image/icon/bnr_ref_cross.gif)
![crossref](/image/icon/bnr_ref_cross.gif)
5. Greven CM, Slusher MM, Weaver RG. Retinal arterial occlusions in young adults. Am J Ophthalmol. 1995; 120:776–83.
![crossref](/image/icon/bnr_ref_cross.gif)
![crossref](/image/icon/bnr_ref_cross.gif)
6. Arnold M, Koerner U, Remonda L. . Comparison of in-tra-arterial thrombolysis with conventional treatment in patients with acute central retinal artery occlusion. J Neurol Neurosurg Psychiatry. 2005; 76:196–9.
![crossref](/image/icon/bnr_ref_cross.gif)
![crossref](/image/icon/bnr_ref_cross.gif)
7. Inatomi Y, Hino H, Hashimoto Y. . Transesophageal echo-cardiography for detection of cardiac diseases in patients with reti-nal artery occlusion. Intern Med. 2001; 40:475–8.
![crossref](/image/icon/bnr_ref_cross.gif)
![crossref](/image/icon/bnr_ref_cross.gif)
8. Furie KL, Kasner SE, Adams RJ. . Guidelines for the pre-vention of stroke in patients with stroke or transient ischemic at-tack: a guideline for healthcare professionals from the american heart association/american stroke association. Stroke. 2011; 42:227–76.
![crossref](/image/icon/bnr_ref_cross.gif)
![crossref](/image/icon/bnr_ref_cross.gif)
9. Broderick JP, Adeoye O, Elm J. Evolution of the modified rankin scale and its use in future stroke trials. Stroke. 2017; 48:2007–12.
![crossref](/image/icon/bnr_ref_cross.gif)
![crossref](/image/icon/bnr_ref_cross.gif)
10. Wong TY, Klein R, Sharrett AR. . Cerebral white matter lesions, retinopathy, and incident clinical stroke. JAMA. 2002; 288:67–74.
![crossref](/image/icon/bnr_ref_cross.gif)
![crossref](/image/icon/bnr_ref_cross.gif)
11. Lindley RI, Wang JJ, Wong MC. . Retinal microvasculature in acute lacunar stroke: a cross-sectional study. Lancet Neurol. 2009; 8:628–34.
![crossref](/image/icon/bnr_ref_cross.gif)
![crossref](/image/icon/bnr_ref_cross.gif)
12. De Silva DA, Liew G, Wong MC. . Retinal vascular caliber and extracranial carotid disease in patients with acute ischemic stroke: the Multi-Centre Retinal Stroke (MCRS) study. Stroke. 2009; 40:3695–9.
13. Yatsuya H, Folsom AR, Wong TY. . Retinal microvascular ab-normalities and risk of lacunar stroke: Atherosclerosis Risk in Communities Study. Stroke. 2010; 41:1349–55.
14. Rim TH, Kim DW, Han JS, Chung EJ. Retinal vein occlusion and the risk of stroke development: a 9-year nationwide population- based study. Ophthalmology. 2015; 122:1187–94.
15. Rim TH, Han J, Choi YS. . Retinal artery occlusion and the risk of stroke development: Twelve-Year Nationwide Cohort Study. Stroke. 2016; 47:376–82.
![crossref](/image/icon/bnr_ref_cross.gif)
![crossref](/image/icon/bnr_ref_cross.gif)
16. Chang YS, Jan RL, Weng SF. . Retinal artery occlusion and the 3-year risk of stroke in Taiwan: a nationwide population-based study. Am J Ophthalmol. 2012; 154:645–52.e1.
![crossref](/image/icon/bnr_ref_cross.gif)
![crossref](/image/icon/bnr_ref_cross.gif)
17. Fiebach JB, Schellinger PD, Jansen O. . CT and diffusion- weighted MR imaging in randomized order. Stroke. 2002; 33:2206–10.
18. Lutsep HL, Albers GW, DeCrespigny A. . Clinical utility of diffusion-weighted magnetic resonance imaging in the assessment of ischemic stroke. Ann Neurol. 1997; 41:574–80.
![crossref](/image/icon/bnr_ref_cross.gif)
![crossref](/image/icon/bnr_ref_cross.gif)
19. Hayreh SS, Podhajsky PA, Zimmerman MB. Retinal artery occlusion: associated systemic and ophthalmic abnormalities. Ophthalmology. 2009; 116:1928–36.
20. Gunes A, Inal EE, Demirci S. . Changes in retinal nerve fiber layer thickness in patients with cerebral infarction: evidence of transneuronal retrograde degeneration. Acta Neurol Belg. 2016; 116:461–6.
21. Park HY, Park YG, Cho AH, Park CK. Transneuronal retrograde degeneration of the retinal ganglion cells in patients with cerebral infarction. Ophthalmology. 2013; 120:1292–9.
![crossref](/image/icon/bnr_ref_cross.gif)
![crossref](/image/icon/bnr_ref_cross.gif)
22. Yoon KC, Mun GH, Kim SD. . Prevalence of eye diseases in South Korea: data from the Korea National Health and Nutrition Examination Survey 2008-2009. Korean J Ophthalmol. 2011; 25:421–33.
![crossref](/image/icon/bnr_ref_cross.gif)
![crossref](/image/icon/bnr_ref_cross.gif)
23. Yang JY, Kim NK, Lee YJ. . Prevalence and factors associated with diabetic retinopathy in a Korean adult population: the 2008-2009 Korea National Health and Nutrition Examination Survey. Diabetes Res Clin Pract. 2013; 102:218–24.
![crossref](/image/icon/bnr_ref_cross.gif)
![crossref](/image/icon/bnr_ref_cross.gif)
24. Shin YU, Cho H, Kim JM. . Prevalence and associated factors of retinal vein occlusion in the Korean National Health and Nutritional Examination Survey, 2008-2012: A cross-sectional ob-servational study. Medicine (Baltimore). 2016; 95:e5185.
Table 1.
Demographics and clinical characteristics of the study subjects
Total (n = 109) | Patient group (n = 53) | Control group (n = 56) | p-value† | p-value‡ | |
---|---|---|---|---|---|
Sex (male:female) | 49:60 | 29:24 | 20:36 | <0.050* | |
Age (years) | 64.57 ± 10.88 | 65.92 ± 12.07 | 63.29 ± 9.56 | 0.207§ | 0.180 |
HTN | 50 (46) | 28 (53) | 22 (39) | 0.156 | 0.123 |
DM | 15 (14) | 9 (17) | 6 (11) | 0.342 | 0.301 |
AF | 12 (11) | 10 (19) | 2 (4) | <0.050* | <0.050* |
HL | 9 (8) | 5 (9) | 4 (7) | 0.664 | 0.564 |
CRF | 1 (1) | 1 (2) | 0 (0) | 0.302 | 0.407 |
IHD | 8 (7) | 6 (11) | 2 (4) | 0.121 | 0.099 |
Table 2.
Fluorescein angiographic characteristics of the study subjects
Total (n = 109) | Patient group (n = 53) | Control group (n = 56) | p-value† | p-value‡ | |
---|---|---|---|---|---|
Arm to retina time | 17.98 ± 3.75 | 18.63 ± 4.49 | 17.36 ± 2.79 | 0.082 | 0.305 |
AV transit time | 9.45 ± 2.21 | 10.06 ± 2.34 | 8.87 ± 1.92 | <0.010* | <0.050* |
Table 3.
Comparison of retinal nerve fiber layer thickness between ipsilateral and contralateral eye
pRNFL thickness(μ m) | Total (n = 104) | Ipsilateral eye (n = 52) | Contralateral eye (n = 52) | p-value* |
---|---|---|---|---|
Average | 100.75 ± 11.55 | 100.63 ± 11.90 | 100.87 ± 11.31 | 0.919 |
Superior | 127.80 ± 17.38 | 128.15 ± 18.04 | 127.44 ± 16.87 | 0.836 |
Temporal | 74.80 ± 12.80 | 75.25 ± 13.75 | 74.35 ± 11.89 | 0.721 |
Inferior | 125.90 ± 19.16 | 126.02 ± 19.70 | 125.79 ± 18.90 | 0.951 |
Nasal | 77.04 ± 14.79 | 76.29 ± 15.46 | 77.79 ± 14.20 | 0.607 |
Table 4.
Comparison between normal group and delayed group in fluorescein angiography
Normal group (n = 34) | Delayed group (n = 19) | p-value† | p-value‡ | |
---|---|---|---|---|
Sex (male:female) | 15:19 | 14:5 | <0.050* | |
Age (years) | 65.76 ± 10.80 | 66.21 ± 14.40 | 0.636§ | 0.645 |
Arm to retina time | 16.04 ± 2.30 | 23.26 ± 3.63 | <0.001*§ | <0.001* |
AV transit time | 9.50 ± 2.12 | 11.08 ± 2.44 | <0.050*§ | <0.050* |
HTN | 18 (53) | 10 (53) | 0.983 | 0.850 |
DM | 7 (21) | 2 (11) | 0.349 | 0.236 |
AF | 1 (3) | 9 (47) | <0.001* | <0.001* |
HL | 5 (15) | 0 (0) | 0.079 | 0.061 |
CRF | 0 (0) | 1 (5) | 0.177 | 0.265 |
IHD | 2 (6) | 4 (21) | 0.095 | 0.074 |
Table 5.
Subgroup analysis according to cerebral infarction territory
ACA territory (n = 4) | MCA territory (n = 30) | PCA territory (n = 10) | p-value* | |
---|---|---|---|---|
Fluorescein angiographic biometry | ||||
Arm to retina time | 14.93 ± 3.44 | 18.90 ± 3.93 | 17.11 ± 3.03 | 0.120 |
AV transit time | 10.93 ± 1.71 | 9.55 ± 2.49 | 10.88 ± 2.25 | 0.132 |
pRNFL thickness | ||||
Average (μ m) | 102.33 ± 11.93 | 99.20 ± 12.67 | 102.60 ± 6.88 | 0.886 |
Superior (μ m) | 134.00 ± 17.52 | 123.53 ± 19.45 | 136.00 ± 12.35 | 0.091 |
Temporal (μ m) | 83.67 ± 23.03 | 74.10 ± 13.89 | 72.40 ± 8.68 | 0.609 |
Inferior (μ m) | 121.00 ± 15.52 | 124.83 ± 18.59 | 124.90 ± 13.37 | 0.849 |
Nasal (μ m) | 73.00 ± 15.00 | 75.83 ± 16.15 | 79.20 ± 14.12 | 0.734 |